These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 29106950)

  • 1. Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy- and asthma-related health outcomes in childhood.
    Impinen A; Nygaard UC; Lødrup Carlsen KC; Mowinckel P; Carlsen KH; Haug LS; Granum B
    Environ Res; 2018 Jan; 160():518-523. PubMed ID: 29106950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort.
    Impinen A; Longnecker MP; Nygaard UC; London SJ; Ferguson KK; Haug LS; Granum B
    Environ Int; 2019 Mar; 124():462-472. PubMed ID: 30684804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes - implications of gender, exposure period and study design.
    Kvalem HE; Nygaard UC; Lødrup Carlsen KC; Carlsen KH; Haug LS; Granum B
    Environ Int; 2020 Jan; 134():105259. PubMed ID: 31733527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.
    Manzano-Salgado CB; Granum B; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Gascón M; Martínez D; Guxens M; Basterretxea M; Zabaleta C; Schettgen T; Sunyer J; Vrijheid M; Casas M
    Int J Hyg Environ Health; 2019 Jul; 222(6):945-954. PubMed ID: 31262703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.
    Chen Q; Huang R; Hua L; Guo Y; Huang L; Zhao Y; Wang X; Zhang J
    Environ Health; 2018 Jan; 17(1):8. PubMed ID: 29343261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between prenatal exposure to perfluoroalkyl substances and asthma in 5-year-old children in the Odense Child Cohort.
    Beck IH; Timmermann CAG; Nielsen F; Schoeters G; Jøhnk C; Kyhl HB; Høst A; Jensen TK
    Environ Health; 2019 Nov; 18(1):97. PubMed ID: 31730470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
    Granum B; Haug LS; Namork E; Stølevik SB; Thomsen C; Aaberge IS; van Loveren H; Løvik M; Nygaard UC
    J Immunotoxicol; 2013; 10(4):373-9. PubMed ID: 23350954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of prenatal exposure to perfluoroalkyl substances in the Slovak birth cohort.
    Richterová D; Fábelová L; Patayová H; Pulkrabová J; Lanková D; Rausová K; Šovčíková E; Štencl J; Hajšlová J; Trnovec T; Palkovičová Murínová Ľ
    Environ Int; 2018 Dec; 121(Pt 2):1304-1310. PubMed ID: 30420127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination.
    Timmermann CA; Budtz-Jørgensen E; Jensen TK; Osuna CE; Petersen MS; Steuerwald U; Nielsen F; Poulsen LK; Weihe P; Grandjean P
    J Immunotoxicol; 2017 Dec; 14(1):39-49. PubMed ID: 28091126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health.
    Ait Bamai Y; Goudarzi H; Araki A; Okada E; Kashino I; Miyashita C; Kishi R
    Environ Int; 2020 Oct; 143():105979. PubMed ID: 32717646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4years among 359 children in the Odense Child Cohort.
    Dalsager L; Christensen N; Husby S; Kyhl H; Nielsen F; Høst A; Grandjean P; Jensen TK
    Environ Int; 2016 Nov; 96():58-64. PubMed ID: 27608427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of prenatal exposure to perfluoroalkyl substances with cord blood adipokines and birth size: The Hokkaido Study on environment and children's health.
    Minatoya M; Itoh S; Miyashita C; Araki A; Sasaki S; Miura R; Goudarzi H; Iwasaki Y; Kishi R
    Environ Res; 2017 Jul; 156():175-182. PubMed ID: 28349882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of prenatal perfluorinated chemicals exposures on pediatric atopy.
    Wang IJ; Hsieh WS; Chen CY; Fletcher T; Lien GW; Chiang HL; Chiang CF; Wu TN; Chen PC
    Environ Res; 2011 Aug; 111(6):785-91. PubMed ID: 21601844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
    Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
    Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of perfluoroalkyl substances exposure with impaired lung function in children.
    Qin XD; Qian ZM; Dharmage SC; Perret J; Geiger SD; Rigdon SE; Howard S; Zeng XW; Hu LW; Yang BY; Zhou Y; Li M; Xu SL; Bao WW; Zhang YZ; Yuan P; Wang J; Zhang C; Tian YP; Nian M; Xiao X; Chen W; Lee YL; Dong GH
    Environ Res; 2017 May; 155():15-21. PubMed ID: 28171771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to perfluoroalkyl substances and allergic outcomes in children: A systematic review and meta-analysis.
    Luo Y; Deji Z; Huang Z
    Environ Res; 2020 Dec; 191():110145. PubMed ID: 32877702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA).
    Preston EV; Webster TF; Oken E; Claus Henn B; McClean MD; Rifas-Shiman SL; Pearce EN; Braverman LE; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2018 Feb; 126(2):027013. PubMed ID: 29488882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.